Tandem Meetings of ASTCT & CIBMTR
The Tandem Meetings of the American Society for Transplantation and Cellular Therapy (ASTCT) and the Center for International Bone Marrow Transplant Research (CIBMTR) represent a pivotal gathering for professionals in the field of hematopoietic cell transplantation and cellular therapies. This multidisciplinary conference unites researchers, clinicians, and industry leaders to share the latest advancements, clinical practices, and research findings that are shaping the future of transplant medicine. Our faculty, fellows, and hospital staff benefit from a rich program featuring keynote presentations, interactive workshops, and in-depth discussions on cutting-edge topics ranging from transplant outcomes to the development of innovative therapies. The Tandem Meetings foster collaboration and knowledge exchange, empowering professionals to enhance patient care and improve outcomes in the diverse field of cellular and transplant medicine.
BMT-CT Tandem Abstracts 2026
3 Interim Clinical Outcomes in Orca-T with Reduced Intensity Conditioning: An Observational Comparison to Registry-Based Post-Transplant Cyclophosphamide Patients
Alejandro Villar-Prados, MD/PhD, Anna Pavlova, MD, PhD, Nathaniel B. Fernhoff, PhD, James Scott McClellan, MD, PhD, Scott Killian, PhD, Robert S. Negrin, MD and Everett H Meyer, MD, PhD
Wednesday, Feb 4, 3:15 PM - 3:30 PM MST at Ballroom AB (Salt Palace Convention Center)
321 High Molecular Weight Isoforms of Thymic Stromal Lymphopoietin Correlate with Presence and Severity of Acute Graft Versus Host Disease
Parveen Shiraz, MD, Ioannis Evangelos Louloudis, MD, Joanna A Liliental, PhD, Lori S. Muffly, MD, MS, Vanessa E Kennedy, MD, Shailja Patel, MS, Robert S. Negrin, MD, Robert Lowsky, MD, Sally Arai, MD, MS, Laura Johnston, MD, Andrew R. Rezvani, MD, Wen-Kai Weng, MD, PhD, Sushma Bharadwaj, MD, Fnu Nitika, BS, Michelle Lauer, PA-C, MPH, Jessica Poyser, BS, Alexandria Jensen, PhD, Anna Pavlova, MD, PhD, David B. Miklos, MD, PhD, Everett H Meyer, MD, PhD, James L.M. Ferrara, MD, DSc, John E. Levine, MD and Judith A. Shizuru, MD, PhD
Thursday, Feb 5, 4:30 PM - 4:45 PM MST at Room 254 A-C (Salt Palace Convention Center)
328 Mature Outcomes from the Phase I Trial of Orca-T and Allogeneic CD19/CD22 CAR-T cells for Adults with High-Risk B-ALL
Alfonso Molina, MD, MPH, Parveen Shiraz, MD, Alyssa Kanegai, MPH, Ayesha Fraser, CCRP, CHRC, Diana Kordek, RN, Caroline Wagner, BS, Lindsay Danley, BS, Arvind Ramakrishnan, BS, Hossein Daghagh, MS, Yingwen Huang, MS, Gaurav Dhapola, MS, Aman Siddiqui, BS, MBA, Sally Arai, MD, MS, Sushma Bharadwaj, MD, Saurabh Dahiya, MD, FACP, Hany Elmariah, MD, Matthew Frank, MD, PhD, Hitomi Hosoya, MD, PhD, Vanessa E Kennedy, MD, Laura Johnston, MD, Everett H Meyer, MD, PhD, Lekha Mikkilineni, MD, MA, Robert Lowsky, MD, Robert S. Negrin, MD, Andrew R. Rezvani, MD, Judith A. Shizuru, MD, PhD, Surbhi Sidana, MD, Wen-Kai Weng, MD, PhD, Catherine McIntyre, PhD, Bita Sahaf, PhD, Steven Feldman, PhD, Crystal L. Mackall, MD, David B. Miklos, MD, PhD, Melody Smith, MD, MS and Lori S. Muffly, MD, MS
Thursday, Feb 5, 3:15 PM - 3:30 PM MST at Ballroom AB (Salt Palace Convention Center)
362 Epixtract: An Artificial Intelligence-Driven Tool to Optimize Data Abstraction for CIBMTR Reporting
Amelia Scheck, BS, Edwin Pua, BS, MS, Emily Jin Yang, Robert Lowsky, MD, David B. Miklos, MD, PhD, Jack Zeng, PhD and Vanessa E Kennedy, MD
Thursday, Feb 5, 11:00 AM - 11:20 AM MST at Room 250 A-F (Salt Palace Convention Center)
369 A Phase 1 Study of KITE-753 or KITE-363 in Patients with Relapsed/Refractory B-cell Lymphoma: Initial Safety and Preliminary Efficacy of KITE-753 and Updated Results of KITE-363
Saurabh Dahiya, MD, FACP, Matthew L. Ulrickson, MD, Jean A. Yared, MD, Patrick M. Reagan, MD, Timothy Voorhees, MD, MSCR, Ran Reshef, MD, MSc, Cameron J. Turtle, MBBS, PhD, Lizamarie Bachier-Rodriguez, MD, Marie José Kersten, MD, PhD, Max S. Topp, MD, Gary L. Simmons, DO, MSHA, Robin Sanderson, FRCPath, PhD, Loretta J. Nastoupil, MD, A. Scott Jung, MD, Enrique Granados, MD, Jinghui Dong, PhD, Joshua Winters, MS, Rhine R. Shen, PhD, Justyna Kanska, PhD, MSc, Myrna Nahas, MD and Sairah Ahmed, MD
Saturday, Feb 7, 10:45 AM - 11:00 AM MST at Ballroom AB (Salt Palace Convention Center)
419 Enhancing the Safety of Ciltacabtagene Autoleucel in Relapsed Multiple Myeloma (MM): Identification of Potentially Modifiable Risk-Factors Associated with Delayed Neurotoxicity and Non-Relapse Mortality
Surbhi Sidana, MD, Brett Reid, PhD, Danai Dima, MD, Lauren C Peres, PhD, MPH, Mahmoud Gaballa, MD, Rahul Banerjee, MD, Oren Pasvolsky, MD, Aimaz Afrough, MD, Christen Dillard, MD, Christpoher Ferreri, MD, Shebli Atrash, MD, Cindy Varga, MD, Andrew J. Portuguese, MD, Masooma Shifa Rana, MD, Hitomi Hosoya, MD, PhD, Lekha Mikkilineni, MD, Vanna Hovanky, MS, Saurabh S. Zanwar, MBBS, Nilesh Kalariya, PhD, RN, AGPCNP-BC, Damian Mikulski, MD, Charlotte B. Wagner, PharmD, Christopher Ryan Cahoon, PharmD, Omar Castaneda, MD, Gabriel De Avila, BS, Christian A Gordillo, MSc, Eli Zolotov, MSc, Ariel Grajales-Cruz, MD, Utkarsh Goel, MD, Aishwarya Sannareddy, MBBS, Jeries Kort, MD, Raffaella Cassano, MD, Shonali Midha, MD, James Davis, PharmD, BCOP, Rebecca Gonzalez, PharmD, BCOP, Megan M. Herr, PhD, Zhuoer Xie, MD, MS, Hamza Hassan, MD, Dr. Sneha Purvey, MD, Marcus J. Geer, MD, Kimberly Green, DO, Fabiana Perna, MD, PhD, Hien Liu, MD, Taiga Nishihori, MD, Jack Khouri, MD, Shahzad Raza, MD, Faiz Anwer, MD, Susan Bal, MD, Omar Nadeem, MD, Ciara L Freeman, MD, PhD, Leyla Shune, MD, Ran Reshef, MD, MSc, Kenneth H Shain, MD, PhD, Melissa Alsina, MD, Rachid C Baz, MD, Douglas W. Sborov, MD, Saurabh Dahiya, MD, FACP, Frederick L Locke, MD, David B. Miklos, MD, PhD, Peter M. Voorhees, MD, Larry D. Anderson Jr., MD, PhD, Luciano J. Costa, MD, PhD, Noa Biran, MD, Shaji Kumar, MD, Yi Lin, MD, PhD, Krina Patel, MD and Doris K. Hansen, MD
Wednesday, Feb 4, 3:15 PM - 3:30 PM MST at Ballroom I (Salt Palace Convention Center)
322 Expanding Donor Access: Comparable One Year Outcomes in 4–6/8 and 7/8 Mismatched Unrelated Donor Transplantation with Ptcy-Based GVHD Prophylaxis (ACCESS Trial)
Monzr M. Al Malki, MD, Stephanie Bo-Subait, MPH, Brent R. Logan, PhD, Sarah Smith, RN, BSN, Erin Leckrone, MBA, Dr. Heather E. Stefanski, MD, PhD, Dr. Jeffery J. Auletta, MD, Stephen R. Spellman, MBS, Craig Malmberg, BS, Prof. Medhat Askar, MD, PhD, Rachel Cusatis, PhD, Brian C. Shaffer, MD, MS, Dipenkumar Modi, MD, Farhad Khimani, MD, Mahasweta Gooptu, MD, Mehdi Hamadani, MD, Martin Maiers, MS, Joseph Stanek, MS, Javier Bolaños Meade, MD, Uttam Rao, MD, MBA, Jordan Milner, MD, Ramzi Abboud, MD, Katarzyna Jamieson, MD, George Carrum, MD, Dr. Bhagirathbhai Dholaria, MD, FACP, William J. Hogan, MB, BCh, Ran Rashef, MD, MSc, Satyajit Kosuri, MD, Rachel Cook, MD, Karen K. Ballen, MD, Alison W. Loren, MD, MSCE, Karilyn T. Larkin, MD, Sally Arai, MD, MS, Muna D. Qayed, MD, MSc, Sung Won Choi, MD, MS, Larisa Broglie, MD, MS, Bronwen E. Shaw, MD, PhD, Steven M Devine, MD and Antonio M. Jimenez Jimenez, MD
Saturday, Feb 7, 10:30 AM - 10:45 AM MST at Ballroom J (Salt Palace Convention Center)
329 Patient Characteristics, Toxicity, and Response after Real World Administration of Obecabtagene Autoleucel and Brexucabtagene Autoleucel for Relapsed Acute Lymphoblastic Leukemia: A Rocca Analysis
Yannis Valtis, MD, Karamjeet S. Sandhu, MD, Rawan Faramand, MD, Amy Zhang, MPH, Katharine Miller, PhD, LaQuisa C. Hill, MD, Ibrahim N. Muhsen, MD, Tamer Othman, MD, Marlise Luskin, MD, MSCE, Evan C. Chen, MD, Caspian Oliai, MD, MS, Georgia Lill, MD, Ryan D. Cassaday, MD, Noam E. Kopmar, MD, Aaron C Logan, MD, PhD, Matthew P. Connor, MD, Talal Hilal, MD, Jae H Park, MD, Melhem M Solh, MD, Caitlin Guzowski, MBA, Jessica T. Leonard, MD, Virginia Tan, MD, Nikeshan Jeyakumar, MD, Hrishikesh K. Srinagesh, MD, MSCR, Muthu V. Kumaran, MD, Rasmus T. Hoeg, MD, Divya Koura, MD, Kaitlyn C. Dykes, MD, Wendy Stock, MD, Vivian Irizarry Gatell, MD, Clayton Jackson, MD, Olalekan O Oluwole, MD, MPH, Dr. Bhagirathbhai Dholaria, MD, FACP, Kristen M O'Dwyer, MD, Jozal W. Moore, MD, Matthew L. Ulrickson, MD, Ali Al Darobi, MD, Kenneth P. Byrd, DO, Fevzi Yalniz, MD, Dr. Stephanie B. Tsai, MD, Timothy E O'Connor, MD, Eunice S. Wang, MD, Ross McCauley, MD, Omer Jamy, MD, Razan Mohty, MD, Gregory Roloff, MD, Katherine C. Sutherland, PA, Ibrahim Aldoss, MD, Bijal D Shah, MD, Lori S. Muffly, MD, MS and Noelle V. Frey, MD
Thursday, Feb 5, 3:30 PM - 3:45 PM MST at Ballroom AB (Salt Palace Convention Center)
335 Phase II Interim Results for Rapcabtagene Autoleucel (YTB323) in Patients with First-Line, High-Risk Large B-cell Lymphoma
Jason Westin, MD, MS, FACP, FASCO, Julio C. Chavez, MD, Stephen J. Schuster, MD, Vladan Vučinić, MD, Patricia A. Young, MD, Patrick Connor Johnson, MD, Stefania Bramanti, MD, Alessandro Rambaldi, MD, Javier Briones Meijide, MD, PhD, Koji Kato, MD, PhD, Juan-Manuel Sancho, MD, Mi Kwon, MD, PhD, Carlos Solano, MD, PhD, Shaun Fleming, MBBS (Hons), PhD, FRACP, FRCPA, Saurabh Dahiya, MD, FACP, Alejandro Martin García-Sancho, MD, PhD, Pedro Marques Ramos, PhD, David Pearson, PhD, Salif Diallo, MSc, Aiesha Zia, MSc, Eduardo Segura, MD, Aisha Masood, MD and Pere Barba, MD, PhD
Friday, Feb 6, 3:30 PM - 3:45 PM MST at Ballroom AB (Salt Palace Convention Center)
339 Favorable Real-World Outcomes of Lisocabtagene Maraleucel in Chronic Lymphocytic Leukemia
Jennifer J. Huang, MD, PhD, Jenna M Voutsinas, MSc, Niranjan S Khaire, MD, DM, Vincenzo Pizzuti, MD, Leyla Shune, MD, Matthew Lei, PharmD, Rodrigo Fonseca, MD, Mohammad Ammad-Ud-Din, MD, Alan Skarbnik, MD, Agrima Mian, MD, Sushma Bharadwaj, MD, Aseel Alsouqi, MD, Bret Wankel, MD, Graham Wehmeyer, MD, Joseph Lukowski, MPH, Alexey V. Danilov, MD, PhD, Tanya Siddiqi, MD, Meghan Thompson, MD, Michael Scordo, MD, Stephanie Franco, MD, Chaitra S Ujjani, MD, Ryan C Lynch, MD, Jordan Gauthier, MD, MSc, William G. Wierda, MD, PhD, Paul M. Barr, MD, Adam S. Kittai, MD, Jonah Shulman, MD, Matthew A. Lunning, DO, FACP, Kerry Rogers, MD, Bita Fakhri, MD, MPH, Brian T. Hill, MD, PhD, Javier Pinilla-Ibarz, MD, PhD, Talal Hilal, MD, Jacob Soumerai, MD, Manali Kamdar, MD, MBBS, Qian "Vicky" Wu, PhD, Nitin Jain, MD and Mazyar Shadman, MD, MPH
Friday, Feb 6, 4:30 PM - 4:45 PM MST at Ballroom AB (Salt Palace Convention Center)
400 Relationship between Social Drivers of Health and Clinician Adherence to Late Effects Screening Among Allogeneic HCT Survivors in the United States
Allison O. Taylor, MD, MS, Sanghee Hong, MD, Salene Jones, PhD, Kevin Ng, MS, Ted A. Gooley, PhD, Neel Bhatt, MBBS, MPH, Elizabeth M. Hellewell, BS, Anthony D Sung, MD, Nausheen Ahmed, MD, Cherie Morey, NP, Sarah Fitzmaurice, NP, Vanessa E Kennedy, MD, Michelle Lauer, PA-C, MPH, Ami J. Shah, MD, Andrew D. Trunk, MD, Betty K. Hamilton, MD, Akshay Sharma, MBBS, MSc, Zoey Phelps-Bergeron, PA-C, LaQuisa C. Hill, MD, Rawan Faramand, MD, Hien Liu, MD, Lena E. Winestone, MD, MSHP, Geoffrey Cheng, MD, Manuel Espinoza Gutarra, MD, Omer Jamy, MD, Mariam T Nawas, MD, Samuel J Yates, MD, MSc, Maria Silvina Odstrcil Bobillo, MD, Brian McClune, DO, Amanda K Johnson, MD, MPH, Miki Nishitani, MD, Takuto Takahashi, MD, PhD, Dr. Jane Koo, MD, Kasiani C Myers, MD, Kris Michael Mahadeo, MD, MPH, Andrea Bauchat, DO, Laurie Pearson, MD, Ritika Walia, MD, Saurabh Chhabra, MD, MS, Whitney Harris, MD, Kelsea Seago, PharmD, BCOP, Spencer Yingling, PharmD, BCOP, Cory M Edgar, DMSc, MPAS, PA-C, Amy Lynn Browning, APRN and Catherine J. Lee, MD, MS
Wednesday, Feb 4, 3:45 PM - 4:00 PM MST at Room 254 A-C (Salt Palace Convention Center)
405 Superior Long-Term Survival with Fludarabine-Melphalan RIC Regimen in Older AML/MDS Patients: A Propensity Score Analysis of CIBMTR Data
Piyanuch Kongtim, MD, PhD, Andrew J. Portuguese, MD, Kim Soyoung, PhD, Andrew Peterson, MS, Hany Elmariah, MD, Lori S. Muffly, MD, MS, Mark B. Juckett, MD, Michael Richard Grunwald, MD, Mariam Nawas, MD, Nelli Bejanyan, MD, Dr. Tania Jain, MD, Veronika Bachanova, MD, PhD, Xia Bi, MD, Ryan J. Stubbins, MD, MSc, Wael Saber, WS, Stefan O. Ciurea, MD and Bart Scott, MD
Friday, Feb 6, 3:30 PM - 3:45 PM MST at Ballroom I (Salt Palace Convention Center)